Aurinia Pharmaceuticals Inc., a biopharmaceutical company, engages in delivering therapies to people living with autoimmune diseases with high unmet medical needs in the United States and Japan. The company offers LUPKYNIS (voclosporin), an...
Q2 2026
Jul 30, 2026
Q1 2026
May 7, 2026
FY 2025
Feb 26, 2026
Q4 2025
Q3 2025
Nov 4, 2025